These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 24449506)
1. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature. Liang JW; Zhang JJ; Zhang T; Zheng ZC Tumour Biol; 2014 May; 35(5):4849-58. PubMed ID: 24449506 [TBL] [Abstract][Full Text] [Related]
2. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis. Wang HB; Liao XF; Zhang J Medicine (Baltimore); 2017 Nov; 96(44):e8437. PubMed ID: 29095284 [TBL] [Abstract][Full Text] [Related]
4. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643 [TBL] [Abstract][Full Text] [Related]
5. HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis. Cao GD; Chen K; Xiong MM; Chen B PLoS One; 2016; 11(8):e0161219. PubMed ID: 27536774 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Variation of Lauren Classification in Gastric Cancer. Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of lymph node-negative metastasis gastric cancer]. Sun D; Xu H; Huang J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354 [TBL] [Abstract][Full Text] [Related]
8. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis. Li X; Zhao H; Gu J; Zheng L World J Surg Oncol; 2016 Feb; 14(1):38. PubMed ID: 26897036 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren's classification]. Li Y; Xue XW; Luo YF; Wu HW; Chen J; Zhou WX Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):486-491. PubMed ID: 29996311 [No Abstract] [Full Text] [Related]
10. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection? Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087 [TBL] [Abstract][Full Text] [Related]
11. IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status. Damasceno EA; Carneiro FP; Magalhães AV; Carneiro Mde V; Takano GH; Vianna LM; Seidler HB; Castro TM; Muniz-Junqueira MI; Amorim RF; Ferreira VM; Motoyama AB J Cancer Res Clin Oncol; 2014 Dec; 140(12):2163-8. PubMed ID: 25323937 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases. Xu J; Zhu R; Fan L; Ge S; Wei W; Li X; Da L; Jia Z; Zhao Z; Ning J; Da J; Peng W; Gu K; Sun G BMC Cancer; 2019 Jul; 19(1):650. PubMed ID: 31266459 [TBL] [Abstract][Full Text] [Related]
13. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis. Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis. Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988 [TBL] [Abstract][Full Text] [Related]
15. HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer. Han S; Park S; An J; Yang JY; Chung JW; Kim YJ; Kim KO; Park DK; Kwon KA; Lee WK; Nam S; Kim JH Sci Rep; 2020 Mar; 10(1):5270. PubMed ID: 32210254 [TBL] [Abstract][Full Text] [Related]
16. Lymph node micrometastases is a poor prognostic factor for patients in pN0 gastric cancer: a meta-analysis of observational studies. Li Y; Du P; Zhou Y; Cheng Q; Chen D; Wang D; Sun T; Zhou J; Patel R J Surg Res; 2014 Oct; 191(2):413-22. PubMed ID: 25060322 [TBL] [Abstract][Full Text] [Related]
17. Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: a meta-analysis. Du J; Shen Y; Yan W; Wang J World J Surg Oncol; 2020 Sep; 18(1):233. PubMed ID: 32873315 [TBL] [Abstract][Full Text] [Related]
18. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis. Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925 [TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of p53 expression in gastric cancer: a meta-analysis. Wei K; Jiang L; Wei Y; Wang Y; Qian X; Dai Q; Guan Q J Cancer Res Clin Oncol; 2015 Apr; 141(4):735-48. PubMed ID: 25316440 [TBL] [Abstract][Full Text] [Related]
20. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients. Cao GD; Chen K; Chen B; Xiong MM BMC Cancer; 2017 Dec; 17(1):841. PubMed ID: 29233126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]